Stefan Willmann
6PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 19, 2025
Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges.James W T Yates, Michael Zientek, Kunal S Taskar
|Sep 19, 2024
Population pharmacokinetic-pharmacodynamic model of elinzanetant based on integrated clinical phase I and II data.Stefan Willmann, Adam Lloyd, Rupert Austin
|Apr 02, 2024
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers.Tianxing Liu, Kensei Hashizume, Eva Krieg
|Dec 12, 2022
Population pharmacokinetics of riociguat in a pediatric population (aged ≥ 6 years) with pulmonary arterial hypertension.Stefan Willmann, Andrea Kerstin Keller, Michaela Meyer
|Jun 06, 2022
Model-informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease.Stefan Willmann, Ibrahim Ince, Maurice Ahsman
|Jun 04, 2021
PK/PD modeling of FXI antisense oligonucleotides to bridge the dose-FXI activity relation from healthy volunteers to end-stage renal disease patients.Stefan Willmann, Eleonora Marostica, Nelleke Snelder
Pageof 1
Frequent Collaborators
2 joint publications
Alexander Solms
1 joint publications
Maurice Ahsman
1 joint publications
Teun Post
1 joint publications
Jörg Lippert
1 joint publications
Tianxing Liu
1 joint publications
Kensei Hashizume
1 joint publications
Eva Krieg
1 joint publications
Huijun Chen
1 joint publications
Yuki Mukaida
1 joint publications
Frauke Friedrichs
